Literature DB >> 33194125

The cascade of benzodiazepine prescribing for hospitalized geriatric patients.

Neshahthari Wijeyakuhan1,2,3,4, Rachel Gruber1,4, Nicholas A Rattray1,3,4,5.   

Abstract

BACKGROUND: Hospitalists increasingly provide care for geriatric patients and little is known about the extent to which hospitalists adhere to evidence-based medication guidelines. This study aimed to characterize hospitalist adherence to BEERS guidelines for prescribing and monitoring benzodiazepines for older adults.
METHODS: We conducted a retrospective chart review of admitted patients aged 70-85 years who had been prescribed benzodiazepine. Charts from 351 patients were analyzed for documentation and decision rationale, which included 638 separate notes.
RESULTS: Benzodiazepines were prescribed 28.2% of the time to address anxiety, which is inconsistent with the BEERS criteria; 39% had adequate data in the impression and plan section of the note to reflect why benzodiazepine was prescribed. Of note, the majority of notes had partial or missing data.
CONCLUSION: Physicians tended to follow guidelines more than advance practice providers. Wide variation persists in prescribing practices and documentation related to benzodiazepines and both could potentially be addressed with further training.
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.

Entities:  

Keywords:  Clinical practice guidelines; beers criteria; documentation; geriatrics; patient safety

Year:  2020        PMID: 33194125      PMCID: PMC7599010          DOI: 10.1080/20009666.2020.1804102

Source DB:  PubMed          Journal:  J Community Hosp Intern Med Perspect        ISSN: 2000-9666


Background

Hospitalists increasingly care for elderly patients, especially ‘baby boomers’[1]. Greater than 40% of hospitalized adults are 65 years and older and by the year of 2030 more than 70 million Americans will be senior citizens [2]. In response to these trends, hospitalists have begun to incorporate geriatric skills into their daily practice [3]. One such skill, and an important patient safety issue is whether hospitalists are currently adhering to evidence-based medication prescribing guidelines for geriatric inpatients. The ‘BEERS Criteria’ guides providers in medication safety and is designed to reduce patient exposure to potentially inappropriate medications (PIMS). Originally created in 1991, the American Geriatrics Society (AGS) began regulating them in 2011 with updates every 3 years. It is unclear, despite its availability, the extent to which hospitalists adhere to current guidelines in local settings [4]. We conducted a retrospective chart review study to determine if providers were following evidence-based guidelines. The purpose of the study was to assess concordant and non-concordant prescribing of benzodiazepines for hospitalized geriatric patients. We hypothesized that providers were not adhering to recommended guidelines and were not providing adequate rationale for their actions. Understanding the patterns and associations related to prescribing and documenting will help us determine if providers are adhering to the current guidelines.

Methods

A retrospective chart review was conducted at an 802- bed tertiary care hospital and non-profit academic medical center with a Level 1 trauma and stroke center. Hospitalists are the admitting providers for most specialties including urology, neurology, nephrology, hematology/oncology, as well as primary internal medicine patients. They collaborate with specialists and are responsible for continuity of care for the acutely ill patients. The daily census for hospitalist care is typically 250–270 patients. Patients included in the chart review were seen by 41 physicians and 24 advanced practice practitioners that comprise the hospitalist service. Patients who were seen by the ACE team (Acute Care of Elderly team) on the day of admission or under the care of the first author were excluded from the study. This study was approved by the IRB. Charts were reviewed for hospitalized patients between the ages 70–85 between 1 January 2017 and December 31st, 2017 for a 2-week period in the hospital. In all, 351 charts were reviewed. Data were collected from the electronic medical record database with assistance from affiliated data scientists. Hospitalist notes were reviewed for encounters on the day benzodiazepines were given as per the inpatient pharmacy records; no more than one progress note was analyzed per day. Key elements included adequate documentation of benzodiazepines and the stated rationale for prescribing the medication. A review team consisting of four independent reviewers reviewed the charts. An audit process to monitor accuracy included team meetings where two reviewers read each chart and came to consensus on analysis. Discrepancies were decided by the geriatric hospitalist (1st author). Each chart was coded for adequate, partial or missing information. ‘Adequate’ charts were classified as those with proper documentation and a stated rationale for prescribing benzodiazepines in the note’s impression and plan. ‘Partial’ documentation was defined as the inclusion of rationale and the prescription of benzodiazepines in the note but missing from the impression and plan. ‘Missing’ was defined as no documentation or rationale found for prescribed benzodiazepines. The intent was to determine whether the reasoning for prescribing the particular benzodiazepine was appropriate based on BEERS guidelines. Primary data were collected via direct data capture and stored electronically in REDCap. Data was entered into REDCap (Research Electronic Data Capture) [5]. The R. Student’s t-test, Wilcoxon rank sum test, and chi-square test were used to determine any statistical association between the care team information, patient data, and prescribing appropriateness. A p-value of <0.05 was considered significant.

Results

Patient population

Between 1 January 2017 and 31 December 2017, the hospitalist admitted/consulted 351 patients between the ages of 70–85 years old. Of the 351 patients, 57.8% were female and 42.2% were male; median age was 75.9 years old; 86.9% were White, 11.7% were Black; 40.7% were discharged to home and 37.3% were discharged to rehab (see Table 1).
Table 1.

Patient characteristics and discharge locations

Demographics (Patients)N (%)
MaleFemale148 (42.2)203 (57.8)
Race/EthnicityWhiteBlackUnknown/RefusedHispanic/LatinoUnknown/Refused305 (86.9)41 (11.7)5 (1.4)3 (0.9)5 (1.4)
Age M (Range)75.9 (70.0 to 85.00)
Marital StatusSingleMarriedDivorcedWidowedOther31 (8.8)187 (53.3)35 (10.0)89 (25.4)4 (1.2)
Discharge locationHomeRehab – Subacute Rehab (SAR) or Acute RehabDied in hospital/HospiceLong Term Acute Care Hospital (LTAC)Unknown/Not reportedNursing Home/Extended StayPrison143 (40.7)131 (37.3)28 (8.0)4 (1.1)34 (9.7)10 (2.8)1 (0.3)
Patient characteristics and discharge locations

Effect of documentation and guideline adherence

638 separate progress notes were reviewed. Based on the quality of progress note documentation, 39.0% were considered ‘adequate,’ 51.3% were ‘partial’ and 9.7% had missing data. Documentation was completed by day-team providers (including MDs and Advanced Practice Providers) 95.5% of the time. Residents accounted for 8.7% of encounters. Based on the rationale provided in the notes, 28.2% of benzodiazepines were prescribed to address anxiety, which is inconsistent with the BEERS criteria (see Tables 2 and 3). In this patient cohort, N = 314 (89%) received benzodiazepines for less than 4 days. N = 37 (11%) received benzodiazepine for more than four days. An example of adequate documentation would be: ‘Alcohol withdrawal-will continue with Librium and taper in 3 days’.
Table 2.

Rationale for benzodiazepine use per documentation and providers

ComponentsFollowed Prescription Guidelines (N = 66)Not Following Prescription Guidelines (N = 511)P
Benzodiazepine TypeALprazoLAM2 (1.9%)104 (98.1%)<0.001
ChlordiazePOXIDE29 (100%)0 
CLonazePAM1 (1.4%)68 (98.6%)<0.001
DiazePAM3 (1.9%)152 (98.1%)<0.001
LORazePAM28 (13.5%)179 (86.5%)<0.001
Multiple3 (42.9%)4 (57.1%)0.7055
OXazePAM04 (100%) 
Documentation AccuracyAdequatePartial54 (21.7%)12 (3.7%)195 (78.3%)316 (96.3%)<0.001
Type of ProviderMDAPPBoth59 (14.7%)3 (2%)4 (18.2%)343 (85.3%)150 (98%)18 (81.8%)<0.001
Provider ShiftDayNight65 (11.7%)1 (4.3%)489 (88.3%)22 (95.7%)0.4496
Provider with residentWithWithout12 (24%)54 (10.2%)38 (76%)473 (89.8%)0.007
Table 3.

Top reasons for benzodiazepine use per documentation

ReasonsN (%)
AnxietyContinued from home medicationConfusionAlcohol Withdrawal181 (28.2)50 (7.8)44 (6.7)42 (6.6)
Rationale for benzodiazepine use per documentation and providers Top reasons for benzodiazepine use per documentation Of the notes written solely by an advanced practice provider (APP) 98% were not guideline concordant. At the same time, 85% of the notes written solely by physicians were not concordant. Physicians were more likely to follow guidelines (p <.05). Progress notes that contained adequate documentation were more likely to display guideline-concordant prescribing practices than those with partial documentation. Whether the providers worked during the day or night or with residents made no difference. Several benzodiazepines were prescribed; the most common were Alprazolam (Xanax), Chlordiazepoxide (Librium), Clonazepam (Klonopin), Diazepam (Valium), and Lorazepam (Ativan). Providers who prescribed Librium always followed guidelines; however, providers did not follow guidelines when prescribing xanax, valium, ativan and klonopin. Ativan was the most frequently non-adherent benzodiazepine prescribed (see Table 2).

DISCUSSION

The primary finding from this retrospective chart review suggests that hospitalists in one large medical center are inconsistently following BEERS criteria. While a small minority of providers offered clear documentation of their clinical decisions and rationale for treatment, most providers included scant information. It was noted that providers copied and pasted notes from previous days with minimal changes, which is a well-known issue [6]. This could be due to lack of time to adequately document. However, in 10% of encounters in which medications were prescribed there was no documentation. It is possible that the provider was not aware of the medications given to the patient vs medications given after the documentation was complete. Nonetheless, it is unclear who prescribed the medications. In addition, we found that physicians followed guidelines more than advanced practice providers. This difference was not affected by whether a provider was working day or night nor if a resident was involved in patient care. In 2019, the BEERS Criteria was updated to include additional medications and a modified grading system. The guidelines are based on AGS criteria, and the evidence and strength measures are based on the American College of Physicians’ (ACP) grading system[8-12]. Few studies have addressed inpatient use of BEERS Criteria [4,7], particularly with respect to prescribing benzodiazepines for older patients. There are a handful of articles suggesting an association between use of benzodiazepines and adverse effects among geriatric patients [8-12]. Our study analyzed various providers’ Benzodiapines prescribing and documentation practices for geriatric patients. Given the fact that there is very little literature on the care of geriatric patients during their hospitalizations, this study is a first step in addressing an important gap in knowledge about the growing geriatric population. For the Benzodiapines prescribed, as mentioned in the results, Ativan was prescribed for anxiety, which is not guideline concordant [4,13]. For the geriatric population Benzodiapines can increase the risk of falls and delirium, an adverse event that can increase the morbidity and mortality [12]. It is concerning to note that in our study, 87 patients had delirium and were on benzodiazepines. If a geriatric patient was truly experiencing anxiety, finding out the underlying cause and providing supportive measures would be the first line of treatment [3,14]. Otherwise prescribing an SSRI (e.g., escitalopram) or SNRI (e.g., Duloxetine) is a better medication for anxiety in geriatric patients [4]. While there is some validity to the claim that prescribing medication is both art and science, clear guidelines do exist for discontinuing or tapering medications in the geriatric population [14]. One specific diagnostic example would be for alcohol withdrawal: while Librium is an appropriate medication, clear instructions need to be given for tapering to discontinue the medication within a certain time frame [11]. This is an important safety issue because of the link between such medications and adverse events among hospitalized older patients. Our study had notable limitations. The sample size was relatively modest. We limited our sample to inpatients older adults’ age 70 yrs and greater who were followed by the hospitalist team as the primary or consulting service. The study was based in one hospital setting; practices in other hospitals may vary. In addition, it was not possible to know why providers did not document their rationale in deciding to prescribe. We do not include the outpatient providers or care.

Future direction

In conclusion, there is considerable non-guideline concordant prescribing of medications in the inpatient geriatric population as well as a lack of documentation. Further research is needed to assess and educate providers on safe prescribing of medications for their geriatric inpatients. Interventions such as educational sessions and feedback of performance data can be helpful in creating a best practice protocol for providers.
  13 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  Update in geriatric medicine: evidence published in 2014.

Authors:  Randall J Morse; Catherine E DuBeau
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 25.391

3.  Evaluation of a Multicomponent Care Transitions Program for High-Risk Hospitalized Older Adults.

Authors:  Peter J Huckfeldt; Bernardo Reyes; Gabriella Engstrom; Qingnan Yang; Sanya Diaz; Samer Fahmy; Joseph G Ouslander
Journal:  J Am Geriatr Soc       Date:  2019-10-01       Impact factor: 5.562

4.  American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2019-01-29       Impact factor: 5.562

5.  The effectiveness of a bundled intervention to improve resident progress notes in an electronic health record.

Authors:  Shannon M Dean; Jens C Eickhoff; Leigh Anne Bakel
Journal:  J Hosp Med       Date:  2014-11-25       Impact factor: 2.960

6.  Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients.

Authors:  G M Batty; C A Oborne; C G Swift; S H Jackson
Journal:  Int J Geriatr Psychiatry       Date:  2000-10       Impact factor: 3.485

7.  Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback.

Authors:  R A Elliott; M C Woodward; C A Oborne
Journal:  Intern Med J       Date:  2001-12       Impact factor: 2.048

8.  The role of geriatrician-hospitalists in the care of older adults: A retrospective cohort study.

Authors:  Liron Sinvani; Maria Carney; Andrzej Kozikowski; Christopher Smilios; Vidhi Patel; Guang Qiu; Meng Zhang; Olawumi Babalola; Yakov Kandov; David Rosenberg; Gisele Wolf-Klein; Renee Pekmezaris
Journal:  Arch Gerontol Geriatr       Date:  2018-03-16       Impact factor: 3.250

9.  Medication use leading to emergency department visits for adverse drug events in older adults.

Authors:  Daniel S Budnitz; Nadine Shehab; Scott R Kegler; Chesley L Richards
Journal:  Ann Intern Med       Date:  2007-12-04       Impact factor: 25.391

10.  "Geriatricizing" hospitalists: identifying educational opportunities.

Authors:  Susan M Friedman; Suzanne M Gillespie; Annette M Medina-Walpole; Thomas V Caprio; Jurgis Karuza; Robert M McCann
Journal:  Gerontol Geriatr Educ       Date:  2013-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.